Skip to main content
Production in Australia)

PRODUCTS

OUR PRODUCTS

CSL Seqirus markets and distributes a number of vaccines and pharmaceutical products to ensure a comprehensive range of products are available to the New Zealand market.

Information on our products is intended for use by New Zealanders:
  • Healthcare professionals who want to know more about a CSL Seqirus product,
  • and individuals who have been prescribed a CSL Seqirus product

Influenza

In-Licensed Products

BCG VACCINE AJV™ is a trademark of AJ Vaccines A/S.
DUKORAL® and JESPECT® are registered trademarks of Valneva Sweden AB.
GARDASIL® 9 is a registered trademark of Merck & Co. Inc Whitehouse Station, NJ, USA.
RABIPUR® is a registered trademark of Bavarian Nordic A/S.
TRAMAL® is a registered trademark of Grunenthal GmbH used by Seqirus as authorised user.
VIMPAT® is a registered trademark used by UCB Pharma GmbH under license.
All other trademarks are registered by Seqirus UK Limited or its affiliates in one or more jurisdictions.

Pandemic Response Solutions

As a global leader in influenza vaccine manufacturing, CSL Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more

 

globe

AP-CRP-23-0001

Seqirus privacy statement
Seqirus privacy statement

This website contains content which is for New Zealand healthcare professionals only. By selecting this box you acknowledge that you are a new Zealand healthcare professional and accessing this website within the scope of your daily practice.